Lenograstim

**Definition:** A recombinant granulocyte colony-stimulating factor that is used to treat or prevent NEUTROPENIA in patients receiving myelosuppressive cancer chemotherapy, for the preparation and collection of blood progenitor cells in PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; and in the treatment of severe congenital neutropenia. Component 1 and Component 2 differ by absence or presence of Neu5Ac in 2-6 linkage to GalNAc side chain.

**Tree numbers:** - D09.400.430.775.200.750 - D12.644.276.374.410.240.350.750 - D12.776.395.240.200.750 - D12.776.467.374.410.240.350.750 - D23.529.374.410.240.350.750